| RS2102527516 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome |
| RS2102527595 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Familial thoracic aortic aneurysm and aortic dissection |
| RS2102527910 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102536359 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS2102536764 |
IRF6
|
Health Risk |
Pathogenic |
Popliteal pterygium syndrome, Van der Woude syndrome |
| RS2102536882 |
IRF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofacial cleft 6, susceptibility to |
| RS2102536939 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2102537180 |
IRF6
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome 1, Van der Woude syndrome 1 |
| RS2102538157 |
CD46
|
Health Risk |
Likely pathogenic |
— |
| RS2102538567 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2102541666 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2102541856 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS2102542129 |
CD46
|
Health Risk |
Likely pathogenic |
— |
| RS2102542809 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2102542857 |
IRF6
|
Health Risk |
Likely pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2102542868 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS2102545062 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102545092 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102545129 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102545206 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102545572 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102545764 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102545818 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102546096 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102546166 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102546321 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102547896 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2102548612 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102548644 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102549080 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2102549174 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2102551463 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS2102551610 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102551941 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102552084 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102552416 |
CD46
|
Health Risk |
Pathogenic |
— |
| RS2102552865 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS2102553716 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2102554196 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102554268 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102554289 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102554465 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102554503 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102557481 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2102559650 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102559671 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102560621 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2102561067 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102561385 |
KCNH1
|
Health Risk |
Pathogenic |
— |
| RS2102561817 |
KCNH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102561827 |
KCNH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Temple-Baraitser syndrome, Temple-Baraitser syndrome |
| RS2102562245 |
CACNA1S
|
Health Risk |
Pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2102564388 |
CENPF
|
Health Risk |
Pathogenic |
— |
| RS2102565260 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102565369 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102565390 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102565547 |
FLVCR1
|
Health Risk |
Likely pathogenic |
— |
| RS2102566615 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS2102566666 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS2102568016 |
EPRS1
|
Health Risk |
Pathogenic |
— |
| RS2102568882 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS2102570274 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS2102572705 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102573564 |
CACNA1S
|
Health Risk |
Likely pathogenic |
— |
| RS2102582533 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2102584825 |
RIT1
|
Health Risk |
Pathogenic |
Non-immune hydrops fetalis, Non-immune hydrops fetalis |
| RS2102590945 |
RIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 8, Noonan syndrome 8 |
| RS2102590960 |
RIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, Noonan syndrome 8 |
| RS2102594816 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102594880 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102598897 |
CD46
|
Health Risk |
Pathogenic |
— |
| RS2102604634 |
FBXO28
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 100, Developmental and epileptic encephalopathy 100 |
| RS2102606427 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2102606531 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2102610607 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102610892 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102610898 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102611118 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102625236 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102628609 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102628622 |
TGFB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102628675 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102629804 |
DARS2
|
Health Risk |
Pathogenic |
— |
| RS2102630058 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2102630084 |
TGFB2
|
Health Risk |
Pathogenic |
Atrial septal defect 1, Atrial septal defect 1 |
| RS2102630133 |
TGFB2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2102630468 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102630480 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2102630527 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102630641 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102630643 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102630646 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102630677 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2102630722 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102634627 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102634730 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome |
| RS2102636006 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS2102636047 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102636056 |
DARS2
|
Health Risk |
Pathogenic |
Spastic ataxia, Spastic ataxia |
| RS2102636059 |
USH2A
|
Health Risk |
Pathogenic |
— |